Cannabis Central: Only these 12 Cannabis Stocks are Higher YTD

These cannabis “momentum” stocks are up 24.6% this year

Below is an article written by Lorimer Wilson of Munknee.com. MunKNEE.com is a new affiliate of eResearch.com.

//

This article highlights the performance of the 12 “momentum” stocks within the Non-penny Pot Stock Index which, given that they represent only 4% of all cannabis stocks, certainly warrant your consideration.

  • 298 cannabis stocks trade on the various Canadian and American stock exchanges and they, collectively, are DOWN 25.9% YTD (as of close of trading on June 5th)
  • 39 of those 298 (i.e. 13%) are non-penny stocks (i.e. trading actively and consistently above US$1/share) which make up the constituents of the Non-penny Pot Stock Index (NPSI) and they are DOWN 4%, on average, YTD (Source)
  • 12 of those 39 are ‘momentum” stocks given that they are UP 24.6% YTD

Given the above you can understand my concentration on the very few winners in the cannabis stock sector. The details of their performance, in descending order, are as follows:

  1. XPhyto(XPHYF) +213.3% YTD
  2. GrowGeneration(GRWG) +60.0% YTD
  3. Rubicon(ROMJ) +29.0% YTD
  4. Corbus(CRBP) +26.6% YTD
  5. Akerna(KERN) +26.5% YTD
  6. Innovative Properties(IIPR) +20.2% YTD
  7. GW Pharma(GWPH) +16.2% YTD
  8. Abacus+10.0% YTD
  9. Columbia(CCHWF) +10.0%YTD
  10. Trulieve(TCNNF) +3.9% YTD
  11. Greenlane(GNLN) +3.7% YTD
  12. Terrascend (TRSSF) N/C YTD

//

To view the original article, please visit https://www.munknee.com/cannabis-central-only-these-12-pot-stocks-out-of-298-are-up-ytd/

//

munKNEE.com is a new affiliate of eResearch.com. To learn more about munKNEE.com, please visit their website and sign-up for their weekly newsletter.

//

About Chris Thompson 394 Articles
Chris Thompson is the President and Director of Equity Research at eResearch. He is a Professional Engineer and CFA Charterholder with a MBA in Investment Management and over 15 years of experience in software development, FinTech, telecommunications, and information technology. Since 2009, he has worked in the Capital Markets in Equity Research, M&A Investment Banking, and Consulting in various sectors.